Dual-energy X-ray absorptiometry and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis using data from the Australian Rheumatology Association Database

Andrea Lyon, Susan Lester, Jessica Stanhope, Tom Lynch, Rachel Black, Claire Barrett, Marissa Lassere, Rachelle Buchbinder, Lyn March, Oscar Russell & Catherine Hill.

Lucia Marcello 1/3/25 Lucia Marcello 1/3/25

The projected burden of arthritis among adults and children in Australia to the year 2040: a population-level forecasting study

Ilana N Ackerman, Alexandra Gorelik, Danielle Berkovic, Rachelle Buchbinder.

Lucia Marcello 16/12/24 Lucia Marcello 16/12/24

Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity

Helen Ramsay, Renea V Johnston, Sheila Cyril, Vanessa Glennon, Liesl Grobler, Deanne M Burgess, Bayden J McKenzie, Samuel L Whittle & Rachelle Buchbinder

Lucia Marcello 5/12/24 Lucia Marcello 5/12/24

The projected burden of arthritis among adults and children in Australia to the year 2040: a population-level forecasting study

Ilana N Ackerman, Alexandra Gorelik, Danielle Berkovic and Rachelle Buchbinder

Lucia Marcello 27/11/24 Lucia Marcello 27/11/24

Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines

Pakeezah Saadat ,Nick Bansback, Marie Falahee, Mickaël Hiligsmann, Peter Tugwell, Rachelle Buchbinder, Samuel Whittle, Dawn P Richards, Laurie Proulx, Holger Schunemann, Pablo Alonso-Coello, Robby Nieuwlaat, Wojtek Wiercioch, Simon Kuper, Jordi Pardo Pardo and Glen Hazlewood